Viviany Taqueti
@VTaqMD
Cardiologist | Director, Cardiac Stress Laboratory | Brigham and Women's Hospital | Harvard Medical
ID:2329527115
https://www.linkedin.com/in/vivianytaqueti 05-02-2014 23:51:16
254 Tweets
1,2K Followers
176 Following
#ICNCCT2024 ASNC Society Viviany Taqueti presents fascinating data on IMAT -intermuscular adipose tissue
And CV risk.
🤔potentially helps explain why the GLP-1 agonists are impacting CV risk?
INOCA- more than meets the eye!
CVS risk doesn't stop with the epicardial vessels. Multimodality imaging can help us understand the complex interplay between reserve, coronary artery disease and the myocardium. Fab talk by Viviany Taqueti! #ICNCCT2024 #YESCCT #WhyCMR
Milton Packer talks to Henrike Arfsten about an exciting presentation from #HeartFailure2024 : Future Treatment of #HF patients - Antiobesity agents?
#HF Asnacks #HF A_ESC #20yearsHFA
The rise of 2 interacting subspecialties: cardiometabolic diseases and the microcirculation
“The microcirculation of the heart and other organs is a major contributor to individual cardiometabolic health outcomes”
👇JACC Journals rb.gy/a90ajo
#ApplyNow : The The Vilcek Foundation Foundation is now accepting applications for the 2025 Vilcek Prizes for Creative Promise in #BiomedicalScience . Young #immigrant scientists in the United States are encouraged to apply for one of three $50K prizes by June 10, 2024. vilcek.org/prizes/vilcek-…
Thank you Danish Cardiovascular Academy Christian Aalkjaer eva prescott for brilliant few days in #København discussing INOCA & HFpEF with basic and clinical 🌎 experts #microcirculation #ScandinavianMindset #Hej
We are profoundly grateful that Dr. Ruth Gottesman, Professor Emerita of Pediatrics at Albert Einstein College of Medicine - Official, has made a transformational gift to #MontefioreEinstein —the largest to any medical school in the country—that ensures no student has to pay tuition again. bit.ly/3wvBj7y
Semaglutide and Cardiovascular Outcomes | NEJM nejm.org/doi/full/10.10…
Thanks Viviany Taqueti and Leslee Shaw for challenging the lack of enrollment of women in this trial.
A missed opportunity to fully assess #cardiovascular outcomes of GLP1 RA in representative patients 🚺🚹 with #obesity and #cardiometabolic disease - Can we do better? ⚖️🫀 #INOCA Leslee Shaw nancyatheart Jill Biden Dr. Monica M. Bertagnolli NEJM rb.gy/j11yds
Obesity-related CV risk is not well captured by BMI, especially in women. In patients without CAD, deficient muscularity (not excess adiposity) by CT body composition = associated w/ MACE, especially HF. bit.ly/48au0zp
#JACCIMG #HeartFailure #MACE #cvCAD #BMI Viviany Taqueti
This has been one of the best experiences for me not only to learn more about clinical trials but also to network! If you’re pondering a career in clinical trials and starting your journey, definitely consider applying for this fellowship today!! Faiez ZANNAD Guiomar Mendieta Badimon #CVCT
Transforming Evidence-Generation in Common Chronic Diseases #HeartMonth 🫀Haider Warraich #hilarymarston Dr. Robert M. Califf nejm.org/doi/full/10.10…